|Aidoc Medical, of Tel Aviv, Israel||iPE flagging||Artificial intelligence solution||Flags incidental pulmonary embolism (iPE) in contrast-enhanced CT||Received the CE mark|
|Cerus Corp., of Concord, Calif||Intercept bloosd system for plasma||Uses amotosalen and ultraviolet A illumination to irreversibly cross-link nucleic acids||Reduces a broad spectrum of viruses, bacteria, protozoa, and contaminating donor leukocytes in plasma components to reduce the risk of transfusion transmitted infections||Received U.S. FDA approval for manufacture of Intercept plasma with a new, alternative plastic disposable kit|
|Novartis Europharm Ltd., of Basel, Switzerland||Enerzair Breezhaler||Fixed dose combination of 3 active substances (indacaterol, glycopyrronium and mometasone furoate) in capsules, to be administered using an inhaler; electronic sensor may be attached to inhaler to track use||Treatment of asthma||European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion to recommend approval|
|Roche Holding AG, of Basel, Switzerland||Elecsys Anti-SARS-CoV-2 antibody test||Immunoassay; has a specificity greater than 99.8% and 100% sensitivity (14 days post-PCR confirmation); runs on Roche's Cobas E analyzers, which can provide results in 18 minutes||For the in-vitro qualitative detection of antibodies (including IgG) to SARS-CoV-2 in human serum and plasma||Received emergency use authorization from the U.S. FDA|
|Zoll Medical Corp., of Chelmsford, Mass.||Supersaturated Oxygen (SSO2) Therapy system||Delivers hyperbaric levels of oxygen directly to the damaged heart muscle immediately after successful revascularization via angioplasty and stenting of the blocked coronary artery||For patients who experience left anterior descending ST-elevation myocardial infarction||Received CE mark approval|
For more information about individual companies and/or products, see Cortellis.